Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3024% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Inari Medical (Standalone through FY2024Q3) by Quarter
Inari Medical (Standalone through FY2024Q3) — Cash & Short-Term Investments ($M) ($M)
Stryker Inari Medical (Standalone through FY2024Q3): $41.1M in Q3 2024, down 53.9% from a year earlier. No newer figure appears in the documents we track.
Latest, Q3 2024
41.1
Period ended Sep 30, 2024
Change on a year earlier
-53.9%
89.2 in Q3 2023
History
17 quarters
Since Q4 2019
Sources
12
Documents cited below
Where the Q3 2024 figure comes from
Source: Inari Medical (NARI) 10Q — FY2024Q3 (filed 2024-10-28) ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Inari Medical (Standalone through FY2024Q3) ($M), quarterly Q4 2019–Q3 2024 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/nari-cash
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.